Allylix uses a fermentation-based, metabolic and protein engineering technology platform to produce terpenes and their derivatives for flavor & fragrance, food ingredients, cosmetics and other markets. The platform enables creation of highly pure, renewable compounds that were previously available only from limited natural resources. Allylix’s technology is protected by 57 patents and is positioned to rapidly develop and produce high-value specialty chemicals at lower cost than traditional methods. The company says it can deliver high-quality products at scalable commercial quantities and at a lower price point. Proceeds from the recent financing are intended to support development and delivery of new compounds in Allylix’s pipeline and to expand the market for its existing products. Allylix develops terpene products and their derivatives for multiple end markets including flavor and fragrance, food ingredients, pharmaceuticals, agriculture and biofuels. The company is based in San Diego, CA. Its near-term commercial focus is on three initial products for the flavor and fragrance industry. The financing described in the article is intended to commercialize those initial products and to advance other products in its pipeline. No operating metrics (revenue or users) are disclosed in the article. Allylix develops a metabolic engineering platform to enable low-cost production of terpene products through yeast fermentation. The platform is protected by 28 patents with additional applications pending and is applicable across flavors and fragrances, food ingredients, fine chemicals, pesticides/crop protection and pharmaceuticals. The company’s first product is nootkatone, a long‑lasting citrus flavor and fragrance used in food, beverage and personal care industries. Allylix plans to commercialize its first three products for the food and fragrance industry and to advance several additional pipeline products. The company previously licensed its technology for specific biofuels products in 2008. The business is based in San Diego, CA. Allylix develops chemicals for the flavor, fragrance, pharmaceutical, nutraceutical, and agricultural markets. Its products are based on terpenes and the company planned six initial products. The company said new funding will be used to launch the first three of those six products. Allylix raised $3.35M in a venture round. Investors in the round included Tech Coast Angels, Life Science Angels, Blue Grass Angels, Pasadena Angels, and Tate & Lyle Ventures; the Tech Coast Angels' lead investor on the deal was Stephen Block. Allylix maintains business operations in San Diego and research and development in Lexington, Kentucky.

Total raised

$31M

Funding rounds

4

Latest round

Equity

Latest activity

Mar 2012